Review
Disease model: pulmonary tuberculosis

https://doi.org/10.1016/S1471-4914(00)01901-8Get rights and content

Abstract

In spite of a massive effort to apply the tools currently available for tuberculosis (TB) control, both in this country and abroad, it is clear that complicating factors [for example, HIV co-infection, drug resistance, lack of patient compliance with chemotherapy, variable efficacy of Bacille Calmette-Guerin (BCG) vaccine] will prevent disease control unless new drugs, vaccines and diagnostic tests are developed 1. The publication of the complete genome sequence of Mycobacterium tuberculosis in 1998 2 has facilitated a directed search for virulence genes, new drug targets, and vaccine antigens. This research effort has been made possible by the availability of highly biologically relevant animal models of pulmonary TB (3).

References (10)

  • C. Dye

    Global burden of tuberculosis. Estimated incidence, prevalence and mortality by country

    J. Am. Med. Assoc.

    (1999)
  • S.T. Cole

    Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

    Nature

    (1998)
  • D.N. McMurray

    Pathogenesis of experimental tuberculosis in animal models

    Curr. Topics. Microbiol. Immunol.

    (1996)
  • I.M. Orme et al.

    Immune responses to tuberculosis in animal models

  • I.M. Orme et al.

    Mouse model of tuberculosis

There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 2001 Elsevier Science Ltd. All rights reserved.